Σάββατο 24 Νοεμβρίου 2018

Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports

Renal cell carcinoma represents 3–5% of adult malignant tumors. Metastases are found in 30–40% of patients and brain metastases occurred in more than 10% of them. Despite significant progress in medical treatm...

https://ift.tt/2SdEOWU

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου